Sutro Biopharma STRO Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on the most recent quarter.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's quick ratio?
- Sutro Biopharma (STRO) reported quick ratio of 3.1× in Q1 2026.
- How has Sutro Biopharma's quick ratio changed year-over-year?
- Sutro Biopharma's quick ratio increased by 44.5% year-over-year, from 2.2× to 3.1×.
- What is the long-term trend for Sutro Biopharma's quick ratio?
- Over 5 years (2020 to 2025), Sutro Biopharma's quick ratio has grown at a -30.9% compound annual growth rate (CAGR), from 12.8× to 2×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.